Company Overview
About Algen Biotechnologies
Algen Biotechnologies is a San Francisco-based drug discovery company that builds computational platforms to decode functional gene networks — using machine learning and genomic data to map the relationships between genes, understand how gene interactions drive disease, and identify novel therapeutic targets that traditional drug discovery approaches miss because they analyze genes in isolation. Founded in 2018 by Chun Hao Huang and Christine Du and a Y Combinator W20 graduate, Algen raised $12.63 million total including a $9 million Seed VC-II round led by Viking Global Investors in February 2022.
Business Model & Competitive Advantage
Algen's platform addresses a fundamental limitation in genomics-based drug discovery: most genetic analysis identifies individual disease-associated genes, but biology operates through networks — a gene's functional impact depends on which other genes it interacts with, which pathways are co-activated, and the cellular context. Algen's functional genomics platform maps these network relationships from large-scale genetic perturbation data, identifying which gene combinations drive disease phenotypes and which targets are central to therapeutic intervention.
Competitive Landscape 2025–2026
In 2025, Algen Biotechnologies competes in the AI drug discovery and computational genomics space with Recursion Pharmaceuticals (RXRX, AI-driven drug discovery), Schrödinger (computational chemistry and biology), Insitro, and academic-spinout gene network platforms for computational drug target identification. The AI drug discovery space has attracted significant investment — Recursion went public, Isomorphic Labs (DeepMind spinout) signed major pharma deals — validating the thesis that computational approaches can accelerate target identification and candidate selection. Viking Global's investment reflects institutional conviction in Algen's gene network approach. The 2025 strategy focuses on advancing lead therapeutic programs from the computational platform into experimental validation, building pharma partnerships for target licensing, and growing the platform's applicability across oncology, neurodegeneration, and metabolic disease.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Algen Biotechnologies is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Compare Algen Biotechnologies with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Algen Biotechnologies? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Algen Biotechnologies Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Algen Biotechnologies vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →